Context Therapeutics, Inc. (CNTX)
0.4676
-0.03
(-6.50%)
USD |
NASDAQ |
Aug 24, 16:00
0.4676
0.00 (0.00%)
After-Hours: 19:19
Context Therapeutics Total Assets (Quarterly) : 46.13M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.13M |
| March 31, 2026 | 58.86M |
| December 31, 2025 | 68.49M |
| September 30, 2025 | 79.23M |
| June 30, 2025 | 87.15M |
| March 31, 2025 | 92.97M |
| December 31, 2024 | 98.13M |
| September 30, 2024 | 86.33M |
| June 30, 2024 | 102.71M |
| March 31, 2024 | 11.05M |
| December 31, 2023 | 16.06M |
| Date | Value |
|---|---|
| September 30, 2023 | 22.99M |
| June 30, 2023 | 27.76M |
| March 31, 2023 | 31.97M |
| December 31, 2022 | 37.97M |
| September 30, 2022 | 42.08M |
| June 30, 2022 | 44.70M |
| March 31, 2022 | 47.03M |
| December 31, 2021 | 51.31M |
| September 30, 2021 | 2.259M |
| June 30, 2021 | 2.719M |
| March 31, 2021 | 2.252M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co., Inc. | 129.80B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 7.962M |
| Shareholders Equity (Quarterly) | 38.17M |
| Debt to Equity Ratio | 0.0064 |
| Current Ratio | 5.786 |
| Net Debt Paydown Yield | -0.02% |